SCHEMBL6603376

SCHEMBL6603376

COc1nc2cc([N+](=O)[O-])c(Oc3ccccc3)cc2nc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPSE Q9Y251 1/20 0.46
XDH P47989 1/20 0.41
HTR6 P50406 1/20 0.41
TTR P02766 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPT P10636 3/20 0.40
PIN1 Q13526 3/20 0.40
PAX8 Q06710 1/20 0.40
PDGFRA P16234 1/20 0.40
KDR P35968 1/20 0.40
ALDH1A1 P00352 4/20 0.40
TDP1 Q9NUW8 2/20 0.40
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
MEN1 O00255 2/20 0.39
THRB P10828 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604334 0.90 ABCG2 (0.43) HPSETTRMAPTPIN1PDGFRA
SCHEMBL6602978 0.77 GRIA1 (0.47) HPSELMNA
SCHEMBL12118834 0.75 HPSE (0.58) HPSEHTR6TTRSMN1; SMN2CYP1A2
SCHEMBL29674894 0.75 PIN1 (0.56) HPSEXDHHTR6TTRCYP2C9
SCHEMBL10957259 0.73 HPSE (0.65) HPSEHTR6TTRSMN1; SMN2CYP1A2
SCHEMBL5717618 0.72 ALDH1A1 (0.67) SMN1; SMN2MAPTALDH1A1TDP1MEN1
SCHEMBL31137919 0.72 ALDH1A1 (0.67) SMN1; SMN2MAPTALDH1A1TDP1MEN1
SCHEMBL10424095 0.72 MEN1 (0.55) HPSEHTR6TTRSMN1; SMN2CYP1A2
SCHEMBL28256429 0.72 HPSE (0.64) HPSEHTR6TTRSMN1; SMN2CYP1A2
SCHEMBL12114418 0.71 HPSE (0.63) HPSEHTR6TTRSMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1020453-B1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERIVATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2004-05-19 EP disclosed
US-6348461-B1 CENTRAL NERVOUS SYSTEM ANTAGONIST WITH HETEROCYCLIC SUBSTITUENTS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1020453-A1 6,7-ASYMMETRICALLY DISUBSTITUTED QUINOXALINECARBOXYLIC ACID DERI VATIVES, ADDITION SALTS THEREOF, AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed